BACKGROUND: Management of rectal cancer has become more complex with multimodality therapy (neoadjuvant chemoradiotherapy and surgery) and this has led to the need to organize multidisciplinary teams. The aim of this study was to report on the planning, implementation and evaluation of an integrated care pathway for neoadjuvant treatment of middle and lower rectal cancer. DESIGN AND SETTING: This was a cross-sectional post-implementation study that was carried out at a public university cancer center. METHODS: The Framework for Program Evaluation in Public Health of the Centers for Disease Control and Prevention (CDC) was used to identify resources and activities; link results from activities and outcomes with expected goals; and originate indicators and outcome measurements. RESULTS: The logic model identified four activities: stakeholders' engagement, clinical pathway development, information technology improvements and training programs; and three categories of outcomes: access to care, effectiveness and organizational outcomes. The measurements involved 218 patients, among whom 66.3% had their first consultation within 15 days after admission; 75.2% underwent surgery < 14 weeks after the end of neoadjuvant treatment and 72.7% completed the treatment in < 189 days. There was 100% adherence to the protocol for the regimen of 5-fluorouracil and leucovorin. CONCLUSIONS: The logic model was useful for evaluating the implementation of the integrated care pathways and for identifying measurements to be made in future outcome studies.
INTRODUCTION
Colorectal cancer is the third leading type of cancer worldwide, accounting for about 1,200,000 new cases and 600,000 deaths annually. 1 According to the National Cancer Institute of Brazil, 2 approximately 34,280 new cases of colorectal cancer were expected to occur in this country in 2016.
About 25% of occurrences of colorectal cancer are located in the rectum. Over the last few decades, there have been major achievements in rectal cancer treatments, with the introduction of neoadjuvant therapy and total mesorectal excision for surgical removal of the tumor. Today, the treatment for middle and lower rectal cancer consists of three phases: first, the staging phase based on colonoscopy, computed tomography (CT) and magnetic resonance imaging (MRI) scans; followed by a second phase of neoadjuvant therapy with concomitant chemotherapy and radiotherapy (nCRT). The last phase is the surgery, including total mesorectal excision.
Integrated care pathways (ICPs) have been adopted into oncology practice as a tool for enhancing both quality and value by limiting undesirable variability and reducing cost, while providing the optimal course of care for a patient's specific diagnosis. 3 ICPs are structured multidisciplinary care plans that detail essential steps in the care for patients with a specific clinical problem. They support translation of clinical guidelines into local protocols and their subsequent application to clinical practice. 4 ICPs have been implemented worldwide, but the reporting of the implementation processes is frequently poor and there is a lack of evidence about their impact.
In the present study, an ICP for neoadjuvant treatment of middle and lower rectal cancer was implemented at a public university cancer center with about 10 This multidisciplinary team standardized practices and constructed a flowchart outlining the sequence and timing of consultations, staging procedures, nCRT and surgery (Figure 1) .
In order to report on the experience of implementing this ICP, a program logic model was used to inform the planning and development of the evaluation process. Logic models are defined as pictures of the way in which planners think their program is going to work.
They comprise the theory and assumptions underlying the program. 5 Logic models originate from the field of program evaluation and are diagrams that convey relationships between contextual factors, inputs, processes, program activities and intended outcomes. [6] [7] [8] They may depict all or some of the following basic components: inputs, activities, outputs and outcomes (Figure 2) . Inputs refer to the resources that go into the program, for it to perform its planned activities, and these can include human, financial, organizational and community resources. Activities refer to processes, tools, events, technology and actions that are implemented through the program and by its staff, in relation to the target population. Outputs are the direct products of program activities, usually measured in countable terms (e.g. the number of multidisciplinary meetings held or the number of first medical consultations booked). Outcomes are the changes that result from the activities and outputs of the program. They describe specific changes to the behavior, knowledge, skills, status and level of functioning of the target population for the program. In summary, logic models are flowcharts that display a logical sequence of steps in program implementation and achievement of desired outcomes. 8 They have been used in a variety of fields, 9 and there is growing recognition of their importance in the planning, implementation and evaluation of funded programs. For example, the United States Centers for Disease Control and Prevention (CDC) have used logic models 8 to evaluate the effectiveness of public healthcare programs and show the success of these programs in achieving intended outcomes, to key stakeholders.
As far as we know, no studies on ICPs for neoadjuvant treatment of middle and lower rectal cancer, with analysis using program logic modelling, had previously been conducted. Furthermore, standardization of treatment for this type of cancer at our institution was not an easy task: there had been complaints about delays in radiotherapy, examinations and surgery; time interval measurements between the phases of treatment were unknown; and there were difficulties in managing all the steps of the forms of rectal cancer care that were in use.
OBJECTIVE
The aim of this study was to report on the planning, implementation and evaluation of an ICP for rectal cancer treatment, using a logic model. 
METHODS

This is a cross
Inputs
Outputs Early outcomes Later outcomes Activities (early/later) that displayed the sequence of logical steps and desired outcomes was used to link the key elements of the model: inputs, activities, outputs, early outcomes and later outcomes.
In the present study, the development of the logic model began with a review of the literature. This identified thinking, policy and research relating to colorectal cancer treatment and the role of ICPs in the delivery of care, both in Brazil and in other countries. It also involved a review of policy and program documents and one-to-one interviews with a sample of six managers and thirteen healthcare professionals involved in the development and delivery of the ICP. This phase resulted in identification of program goals, objectives and inputs.
The inputs were listed as the service users (patients included in the care pathway) and the resources (human resources and facilities) that were needed to carry out activities ( Table 1) .
Background
Period prior to implementation of the integrated care pathway: A public teaching hospital specializing in oncology opened its doors in May 2008, to treat public healthcare system patients who had been diagnosed with cancer. Patients were admitted by medical oncologists or surgeons. Although the established multimodal treatment for middle or lower rectal cancer consisted of neoadjuvant chemoradiotherapy followed by surgical resection, there was no coordination between the phases, which harmed the continuity of care. Until 2010, radiotherapy was done in a different service.
Goal
To implement an integrated care pathway for neoadjuvant treatment of rectal cancer, consisting of radiotherapy with 5040 cGy delivered in 28 fractions (540 cGy in the boost phase and 4500 cGy in the pelvic phase), over a five-week period. Concomitant chemotherapy (FULV regimen 12 with 350 mg/m 2 of 5-fluorouracil and 20 mg/m 2 of leucovorin) was delivered as two five-day courses during the first and fifth weeks of radiotherapy. Surgery with total mesorectal excision consisted of open rectosigmoid resection (ORR), laparoscopic rectosigmoid resection (LRR) or abdominoperineal resection (APR).
Objectives
To manage all steps of the treatment for middle and lower rectal cancer and provide multidisciplinary continuity of care. Inputs
Service users
Inclusion Criteria: · Patients with rectal cancer Exclusion Criteria: · Patients with metastatic disease at diagnosis · Patients who were unable to undergo neoadjuvant treatment: clinical condition precluded the use of nCRT; or immediate surgery was indicated; or a rapid course of neoadjuvant radiotherapy was indicated · Patients who had previously been treated for cancer · Patients who had not adhered to the nCRT regimen
Resources
Human Resources: medical oncologists, gastrointestinal surgeons, radiation oncologists, endoscopists, radiologists, pathologists, anesthesiologists, physicians, nurses, dieticians, social workers, psychologists, physiotherapists, hospital administrators and data managers Facilities: chemotherapy sector, radiotherapy sector, operating rooms, inpatient units, consultation rooms, imaging service and electronic medical records Activities
Stakeholder engagement
· Clinical staff engagement: Multidisciplinary meetings were held under the leadership of a board of directors. Medical oncologists, surgeons, radiation oncologists, radiologists, pathologists, clinicians and anesthesiologists reviewed the neoadjuvant treatment protocol for middle and lower rectal cancer and defined the intervals between the phases of the treatment.
Clinical pathway development
· An integrated care pathway was designed as a flowchart by the administrative group. · Identification of patients' input into the clinical pathway · Definition of the time interval between record screening and the first medical consultation · Booking first medical consultations on the pathway · Staging test standardization · Definition of term reports · Sharing of chemotherapy and radiotherapy session schedules · Active monitoring of surgery requests · Definition of time interval between neoadjuvant treatment and surgery
Information technology improvements
· Enablement of pathway patient identification using a flag added to the electronic patient charts · Development of a report to identify pathway patients who have consultations and tests scheduled · Development of a report to identify pathway patients who do not have any scheduling · Development of a report to calculate dates of future steps on the pathway, to help in reception sector scheduling · Development of the flag deactivation process
Training program
· Training program for outpatient reception workers to enable schedule tests and consultations in accordance with the flowchart · Training program to enable use of the reports that have been developed · Training program to activate flags: regulation sector · Training program to deactivate flags: physicians 
RESULTS
The clinical staff and the administrative team were the stakehold- 
DISCUSSION
ICP is an administrative and care milestone that combines administrative support with care needs in order to ensure multidisciplinary care. Implementation of a clinical pathway within daily practice is challenging, especially in public hospitals with high demand and limited resources.
Regarding pathway implantation, the initial activity of engaging stakeholders showed that there was a need to standardize and disseminate the clinical pathway between the various medical specialties and find solutions to ensure that the treatment steps were achieved. Previously, referral to another team or to the next stage was done only after the end of the preceding stage. Some adaptations were made because of a lack of time resources: for example, the medical oncologists prescribed chemotherapy until chemoradiotherapy sessions started to be scheduled, because of difficulties in coordinating the sessions. Scheduling the surgery at the right time after neoadjuvant treatment was also a challenge.
In this regard, the National Comprehensive Cancer Network, through its clinical practice guidelines for oncology, advocates a multidisciplinary approach involving oncologists, gastroenterologists, surgeons, radiation oncologists and radiologists. 11 Some institutions have organized their multidisciplinary teams through systematic meetings, in the form of "tumor boards". 12 However, there is a lack of research demonstrating the effectiveness of the multidisciplinary approach. [13] [14] [15] [16] To develop the clinical pathway, administrative support was necessary to ensure that the flowchart design defined by the medical teams within daily practice was implemented. The care teams (multiprofessional and medical) raised any critical issues and needs that had to be resolved.
Regarding inputs and activities, communication problems
between the teams were a barrier that needed to be overcome. perspective. These authors noted that there was some difficulty in putting the indicators into operation because of a lack of data source specification and collection methods. They also showed that indicators focusing on the surgical treatment predominated and pointed out that there was a need to measure the quality of care.
In this study, the indicators showed opportunities for improvement. Specific studies and actions are needed in order to increase the percentage of patients with ranges of values for these indicators that are within the targets.
Management of middle and lower rectal cancer has become complex with the multimodality therapy of nCRT and surgery. This has led to a need to monitor access to all phases of the treatment. Eldin et al.
showed that there were difficulties in relation to adherence to treatment guidelines among stage II/III rectal cancer patients in Alberta, Canada, because of lack of access to medical oncologists among patients, and the distance from these patients' homes. 19 Gallego-Plazas et al. evaluated rectal cancer treatment in a tertiary-level hospital and pointed out that delays in the intervals between the different phases of treatment and lack of coordination were critical factors. 20 In relation to effectiveness of care, there is no agreement regarding the impact on overall survival of multimodal treatment for rectal cancer. Wiegering et al. reported that increased use of neoadjuvant therapy and total mesorectal excision led to improvement of overall survival. 21 Chang et al. also reported that use of neoadjuvant treatment was increasing but did not find any differences in five-year overall survival. 14 The organizational outcome indicators selected in the present study were related to resource use and cost evaluation. Although use of integrated care pathways has been correlated with improvement to the quality of care, cost reduction and optimization of resource allocation, 22 few studies have quantified their effectiveness.
Some limitations of the present study can be highlighted. Firstly, early and later outcomes (Figure 4) were not evaluated separately.
Furthermore, since the purpose of the study was to analyze an ICP implementation process, outcomes before and after the intervention were not compared. Secondly, it might be argued that a wider group of participants could have been included to reflect differences in views among participants from similar backgrounds. Although the proposal to evaluate ICPs for rectal cancer treatment came from a hospital/university joint research network and members of this network formed the research team, inclusion of a wider group of stakeholders in the process generated further ownership and support for the subsequent evaluation. Thus, we believe that this exercise was conducted among a reasonably coherent group of stakeholders, across the range of roles involved in rectal cancer treatment.
We found that the logic model was an effective planning and evaluation tool and a useful project management resource that greatly increases the likelihood that ICP goals would be reached, consistently with these aims. However, some of the difficulties in developing a logic model were significant, including the availability of time among the stakeholders, the requirement for trained staff to conduct the evaluation process and the need for institutional commitment to the project.
Future studies should provide comparisons with the period before the implementation of the ICP, in order to evaluate early outcomes relating to access to care (reduction of the time intervals of the treatment), effectiveness of care (reduction of the total duration of the treatment) and organizational outcomes (resource use).
CONCLUSIONS
Implementation of an ICP for rectal cancer treatment, analyzed by means of a logic model approach, was feasible and informed the design of this complex intervention for evaluation of rectal cancer care.
